首页> 外文期刊>British Journal of Clinical Pharmacology >Letter to the Editors Amitriptyline for clozapine-induced nocturnal enuresis and sialorrhoea
【24h】

Letter to the Editors Amitriptyline for clozapine-induced nocturnal enuresis and sialorrhoea

机译:致阿米替林致氯氮平诱发的夜间遗尿和唾液痛的信

获取原文
获取原文并翻译 | 示例
       

摘要

Clozapine is an atypical antipsychotic of the dibenzodi-azepine class which is useful in treating resistant schizo-phrenia. Besides agranulocytosis, which is potentially life-threatening, there are other disabling adverse effects of clozapine such as seizures, hypotension, sialorrhoea, constipation, nocturnal enuresis and weight gain. Cloz-apine-induced sialorrhoea occurs at a rate of approxi-mately 30%, although it varies from 10 to 80% in the literature. Nocturnal enuresis is a less frequently reported side-effect and incidence varies from 0.23% to 41% .
机译:氯氮平是一种非典型的抗精神病药,二苯并二氮杂卓类,可用于治疗耐药性精神分裂症。除粒细胞缺乏症(可能威胁生命)之外,氯氮平还具有其他致残的不良作用,例如癫痫发作,低血压,唾液痛,便秘,夜间遗尿和体重增加。尽管在文献中从10%到80%不等,但Cloz-apine诱导的唾液流涎的发生率约为30%。夜间遗尿是较少报道的副作用,发生率从0.23%到41%不等。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号